Lilly's Second Insulin Injection Brings Total to $240m Over 5 Months
Lilly says another investment in its Indianapolis facility will add a second insulin cartridge-filling line and is driven by the increasing prevalence of diabetes.
Archives for April 2, 2013
AmerisourceBergen Exits Contract Packaging and Canadian Distribution
AmerisourceBergen has sold AndersonBrecon for $308m, exiting the contract packaging business in order to concentrate on its core business.
GSK to Expand Supplier "Risk Mapping" in 2013
GSK will conduct more audits of key suppliers in 2013 as part of a ‘risk mapping’ effort to safeguard its £9bn ($13bn) a year outsourcing spend.
Changes to Indian Clinical Trial Compensation Rules Expected
Concern over controversial new Indian rules on trial participant compensation for study-related injuries is likely to spark changes that may be difficult and time consuming to implement, according to industry sources.
Japanese API Manufacturer Hit with Warning, US Import Alert after Gross Violations
The US FDA has reprimanded and halted all imports from Japanese API manufacturer Asada Milling Co. after finding its manufacturing equipment “corroded, rusted, chipped of paint, and coated with an unidentified white powder,” the agency said in its...
New Vietnam Plant as Sanofi Leads the Way in Emerging Markets
Sanofi says it is “the leading healthcare company in emerging markets” as it invests $75m in a new manufacturing facility in Vietnam.
Lonza Reaffirms Commitment to Teva Biosimilars JV in Light of 'Inaccurate' Reports
Lonza has reiterated its commitment to its biosimilars JV with Teva after various news stories hinted the future of the partnership was in doubt.